Shougang Guo

980 total citations
55 papers, 698 citations indexed

About

Shougang Guo is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shougang Guo has authored 55 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Neurology, 12 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shougang Guo's work include Autoimmune Neurological Disorders and Treatments (18 papers), Peripheral Neuropathies and Disorders (12 papers) and Genetics and Neurodevelopmental Disorders (6 papers). Shougang Guo is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (18 papers), Peripheral Neuropathies and Disorders (12 papers) and Genetics and Neurodevelopmental Disorders (6 papers). Shougang Guo collaborates with scholars based in China, France and United States. Shougang Guo's co-authors include Baojie Wang, Ziling Zeng, Chunjuan Wang, Yang Yang, Yifeng Du, Yifeng Du, Shi Tang, Fusheng Zhang, Qinghua Zhang and Wenyu Shao and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Shougang Guo

48 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shougang Guo China 16 267 162 101 89 83 55 698
Nila Volpi Italy 16 191 0.7× 313 1.9× 98 1.0× 65 0.7× 92 1.1× 48 889
Yuzhong Wang China 19 254 1.0× 326 2.0× 75 0.7× 51 0.6× 58 0.7× 71 968
Zufeng Wang China 19 199 0.7× 402 2.5× 171 1.7× 57 0.6× 45 0.5× 41 935
Haijun Bao China 11 95 0.4× 320 2.0× 113 1.1× 40 0.4× 53 0.6× 20 583
Damir Nizamutdinov United States 13 91 0.3× 150 0.9× 90 0.9× 31 0.3× 42 0.5× 30 590
Fengyuan Che China 13 243 0.9× 188 1.2× 98 1.0× 31 0.3× 32 0.4× 49 685
Mingchao Shi China 12 164 0.6× 245 1.5× 128 1.3× 115 1.3× 35 0.4× 37 864
Yifeng Du China 15 149 0.6× 212 1.3× 61 0.6× 19 0.2× 75 0.9× 36 653
Laura Bărcuţean Romania 12 133 0.5× 160 1.0× 32 0.3× 110 1.2× 31 0.4× 42 528

Countries citing papers authored by Shougang Guo

Since Specialization
Citations

This map shows the geographic impact of Shougang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shougang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shougang Guo more than expected).

Fields of papers citing papers by Shougang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shougang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shougang Guo. The network helps show where Shougang Guo may publish in the future.

Co-authorship network of co-authors of Shougang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Shougang Guo. A scholar is included among the top collaborators of Shougang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shougang Guo. Shougang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dou, Jingjing, et al.. (2024). Case report: paraneoplastic cerebellar degeneration associated with anti-Yo antibody successfully treated with ofatumumab. Frontiers in Immunology. 15. 1476397–1476397.
4.
Guo, Shougang, et al.. (2023). Sex Differences in the Association between Hemoglobin A1c and Cerebral White Matter Lesions in the General Japanese Population. Acta Neurologica Scandinavica. 2023. 1–10. 1 indexed citations
5.
Zhang, Fangyuan, Guang‐Yin Xu, Xiaoyu Zhang, et al.. (2023). Clinical characteristics and short-term outcomes of Japanese encephalitis in pediatric and adult patients: a retrospective study in Northern China. Frontiers in Neurology. 14. 5 indexed citations
6.
7.
Liu, Fei, et al.. (2022). Influential Factors, Treatment and Prognosis of Autoimmune Encephalitis Patients With Poor Response to Short-Term First-Line Treatment. Frontiers in Neurology. 13. 861988–861988. 5 indexed citations
8.
Zhao, Shuo, Xunyao Hou, Song Xu, et al.. (2022). Insidious Attentional Deficits in Patients With Cerebral Small Vessel Disease Revealed by Attention Network Test. Frontiers in Neurology. 13. 865307–865307. 4 indexed citations
9.
Li, Jiao & Shougang Guo. (2022). Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases. Frontiers in Immunology. 13. 966766–966766. 9 indexed citations
10.
Gao, Xiang, Yanchen Xie, Hong-Jun Hao, et al.. (2021). Complement C3 polymorphism is associated with the susceptibility of myasthenia gravis in Chinese adult patients. Journal of Neuroimmunology. 353. 577487–577487. 4 indexed citations
11.
Wang, Jing, et al.. (2020). LncRNA DGCR5 promotes non-small cell lung cancer progression via sponging miR-218-5p. SHILAP Revista de lepidopterología. 3 indexed citations
12.
Zeng, Ziling, et al.. (2020). Clinical features of adult anti-N-methyl-d-aspartate receptor encephalitis after Japanese encephalitis. Journal of the Neurological Sciences. 417. 117080–117080. 7 indexed citations
13.
Xiang, Yuanyuan, et al.. (2020). Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155. Journal of Neuroimmunology. 345. 577280–577280. 22 indexed citations
14.
Devaux, Jérôme, Yan Wang, Yan Wang, et al.. (2019). Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China. Journal of Neuroimmunology. 337. 577074–577074. 18 indexed citations
15.
Zeng, Ziling, et al.. (2017). Lower 25-Hydroxyvitamin D is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis. The journal of nutrition health & aging. 22(1). 38–43. 13 indexed citations
16.
Zeng, Ziling, et al.. (2017). Trans-caryophyllene inhibits amyloid β (Aβ) oligomer-induced neuroinflammation in BV-2 microglial cells. International Immunopharmacology. 51. 91–98. 59 indexed citations
17.
Wang, Baojie, et al.. (2017). Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour. Journal of the Neurological Sciences. 377. 127–132. 26 indexed citations
18.
Luo, Changjiang, et al.. (2017). Spectrum construction of differentially expressed circular RNAs in patients with leukoaraiosis and function analysis of differentially expressed genes. Molecular Medicine Reports. 16(3). 2563–2569. 1 indexed citations
19.
20.
Huang, Xiaojiang, Shougang Guo, & Wei Wang. (2007). Effects of minimally invasive puncture and drainage of intracranial hematoma on the blood-brain barrier in patients with cerebral hemorrhage. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(1). 101–103. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nila Volpi Breakdown of academic impact, for papers by Yuzhong Wang Breakdown of academic impact, for papers by Zufeng Wang Breakdown of academic impact, for papers by Haijun Bao Breakdown of academic impact, for papers by Damir Nizamutdinov Breakdown of academic impact, for papers by Fengyuan Che Breakdown of academic impact, for papers by Mingchao Shi Breakdown of academic impact, for papers by Yifeng Du Breakdown of academic impact, for papers by Laura Bărcuţean
Rankless by CCL
2026